FI66003C - Analogifoerfarande foer framstaellning av en terapeutiskt anvaendbar penicillansyra-1,1-dioxid och derivat daerav - Google Patents

Analogifoerfarande foer framstaellning av en terapeutiskt anvaendbar penicillansyra-1,1-dioxid och derivat daerav Download PDF

Info

Publication number
FI66003C
FI66003C FI781800A FI781800A FI66003C FI 66003 C FI66003 C FI 66003C FI 781800 A FI781800 A FI 781800A FI 781800 A FI781800 A FI 781800A FI 66003 C FI66003 C FI 66003C
Authority
FI
Finland
Prior art keywords
dioxide
acid
penicillanic acid
ethyl acetate
added
Prior art date
Application number
FI781800A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI781800A (fi
FI66003B (fi
Inventor
Wayne Ernest Barth
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27122691&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI66003(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of FI781800A publication Critical patent/FI781800A/fi
Priority to FI832515A priority Critical patent/FI71740C/fi
Publication of FI66003B publication Critical patent/FI66003B/fi
Application granted granted Critical
Publication of FI66003C publication Critical patent/FI66003C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI781800A 1977-06-07 1978-06-06 Analogifoerfarande foer framstaellning av en terapeutiskt anvaendbar penicillansyra-1,1-dioxid och derivat daerav FI66003C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI832515A FI71740C (fi) 1977-06-07 1983-07-08 Vid framstaellning av terapeutiskt aktiv penicillansyra-1,1-dioxid saosom mellanprodukter anvaendbara i penicillansyra-1-oxider.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80432077A 1977-06-07 1977-06-07
US80432077 1977-06-07
US87938178A 1978-02-21 1978-02-21
US87938178 1978-02-21

Publications (3)

Publication Number Publication Date
FI781800A FI781800A (fi) 1978-12-08
FI66003B FI66003B (fi) 1984-04-30
FI66003C true FI66003C (fi) 1984-08-10

Family

ID=27122691

Family Applications (1)

Application Number Title Priority Date Filing Date
FI781800A FI66003C (fi) 1977-06-07 1978-06-06 Analogifoerfarande foer framstaellning av en terapeutiskt anvaendbar penicillansyra-1,1-dioxid och derivat daerav

Country Status (35)

Country Link
AR (1) AR224111A1 (xx)
AT (2) AT360649B (xx)
AU (1) AU513636B2 (xx)
BE (1) BE867859A (xx)
BG (2) BG34614A3 (xx)
CH (1) CH634073A5 (xx)
CS (1) CS208472B2 (xx)
DD (2) DD148585A5 (xx)
DE (2) DE2824535C3 (xx)
DK (1) DK155740C (xx)
EG (1) EG13869A (xx)
FI (1) FI66003C (xx)
FR (2) FR2393804A1 (xx)
GB (1) GB2000138B (xx)
GR (1) GR72255B (xx)
HK (1) HK13184A (xx)
HU (1) HU180042B (xx)
IE (1) IE47079B1 (xx)
IL (2) IL54867A (xx)
IN (1) IN149747B (xx)
IT (1) IT1096381B (xx)
KE (1) KE3355A (xx)
LU (1) LU79774A1 (xx)
MY (1) MY8500092A (xx)
NL (2) NL180009C (xx)
NO (2) NO151746C (xx)
NZ (1) NZ187476A (xx)
OA (1) OA05964A (xx)
PH (3) PH26810A (xx)
PL (1) PL114501B1 (xx)
PT (1) PT68146A (xx)
SE (2) SE436206B (xx)
SG (1) SG65383G (xx)
SU (1) SU860706A1 (xx)
YU (1) YU41829B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77306A1 (xx) * 1977-05-09 1979-01-18
DE2912511C2 (de) * 1977-06-07 1982-06-24 Pfizer Inc., 10017 New York, N.Y. Pharmazeutische Zusammensetzung, enthaltend Penicillansäure
DK155942C (da) * 1977-12-23 1989-10-23 Pfizer Analogifremgangsmaade til fremstilling af 6-aminopenicillansyre-1,1-dioxid og fysiologisk acceptable syreadditions- og basesalte deraf.
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
US4241050A (en) * 1978-09-01 1980-12-23 Pfizer Inc. Penam 1,1-dioxides as beta-lactamase inhibitors
CA1158639A (en) * 1978-12-11 1983-12-13 Eric M. Gordon 6-bromopenicillanic acid sulfone
IE49880B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd Penicillin derivatives
SE449103B (sv) * 1979-03-05 1987-04-06 Pfizer Sett att framstella penicillansyra-1,1-dioxid samt estrar derav
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4420426A (en) 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
GB2045236A (en) * 1979-03-26 1980-10-29 Hoechst Uk Ltd Oxapenem derivatives
US4244951A (en) 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4309347A (en) * 1979-05-16 1982-01-05 Pfizer Inc. Penicillanoyloxymethyl penicillanate 1,1,1',1'-tetraoxide
IE49770B1 (en) * 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
DE3051044C2 (xx) * 1979-06-19 1989-03-30 Leo Pharmaceutical Products Ltd. A/S (Loevens Kemiske Fabrik Produktionsaktieselskab), Ballerup, Dk
US4256733A (en) * 1979-09-26 1981-03-17 Pfizer Inc. Acetoxymethyl penam compounds as β-lactamase inhibitors
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
IL61880A (en) * 1980-01-21 1984-11-30 Bristol Myers Co 2beta-chloromethyl-2alpha-methylpenam-3alpha-carboxylic acid sulfone derivatives,their preparation and pharmaceutical compositions containing them
US4488994A (en) * 1980-09-08 1984-12-18 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4432903A (en) * 1980-09-08 1984-02-21 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
US4474698A (en) * 1980-12-11 1984-10-02 Pfizer Inc. Process for preparing esters of penicillanic acid sulfone
US4419284A (en) * 1981-03-23 1983-12-06 Pfizer Inc. Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide
EP0069962B1 (en) * 1981-07-15 1985-01-02 Kanebo, Ltd. Novel ester of 1,1-dioxopenicillanic acid, process for production thereof, and use thereof as beta-lactamase inhibitor
PT76526B (en) * 1982-04-19 1986-01-21 Gist Brocades Nv Preparation of 6-alpha-bromo- and/or 6,6-dibromopenicillanic acid 1,1-dioxides
US4502988A (en) * 1983-08-08 1985-03-05 Eli Lilly And Company Oxidation process
EP0139047A1 (en) * 1983-10-18 1985-05-02 Gist-Brocades N.V. Process for the preparation of 6,6-dibromopenicillanic acid 1,1-dioxide
US4647457A (en) * 1983-12-16 1987-03-03 Hoffmann-La Roche Inc. Penicillanic acid derivatives
JPH07103129B2 (ja) * 1986-04-10 1995-11-08 レオ・ファーマシューティカル・プロダクツ・リミテッド・エイ／エス（レーベンス・ケミスケ・ファブリック・プロデュクチオンスアクチーセルスカブ） ペニシラン酸誘導体の改良された新規合成方法
GB8808701D0 (en) * 1988-04-13 1988-05-18 Erba Carlo Spa Beta-lactam derivatives
CN102977120B (zh) * 2012-12-14 2015-05-27 江西富祥药业股份有限公司 一种舒巴坦匹酯制备及结晶方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3197466A (en) * 1961-10-30 1965-07-27 Smith Kline French Lab Penicillin sulfoxides and process
LU77306A1 (xx) * 1977-05-09 1979-01-18
AU3796278A (en) * 1977-07-13 1980-01-17 Glaxo Group Ltd Penams and azetidinones

Also Published As

Publication number Publication date
GB2000138B (en) 1982-03-03
DK155740C (da) 1989-10-23
AT360649B (de) 1981-01-26
DE2824535B2 (de) 1980-05-14
FR2393805B1 (xx) 1984-02-24
AT364084B (de) 1981-09-25
SE447995B (sv) 1987-01-12
YU41829B (en) 1988-02-29
PH16465A (en) 1983-10-20
PL114501B1 (en) 1981-02-28
DD140888A5 (de) 1980-04-02
FR2393805A1 (fr) 1979-01-05
FI781800A (fi) 1978-12-08
IL62168A0 (en) 1981-03-31
FI66003B (fi) 1984-04-30
HK13184A (en) 1984-02-24
DK251478A (da) 1978-12-08
IT1096381B (it) 1985-08-26
SE8305916L (sv) 1983-10-27
LU79774A1 (fr) 1980-01-22
AU513636B2 (en) 1980-12-11
DD148585A5 (de) 1981-06-03
GB2000138A (en) 1979-01-04
NL930064I2 (nl) 1994-04-18
NO823126L (no) 1978-12-08
CS208472B2 (en) 1981-09-15
BG34615A3 (en) 1983-10-15
IT7824270A0 (it) 1978-06-06
NL7806126A (nl) 1978-12-11
IL54867A (en) 1981-11-30
IE781140L (en) 1978-12-07
SE7806628L (sv) 1978-12-08
HU180042B (en) 1983-01-28
SE8305916D0 (sv) 1983-10-27
BG34614A3 (en) 1983-10-15
IL54867A0 (en) 1978-08-31
ATA411278A (de) 1980-06-15
NZ187476A (en) 1982-08-17
CH634073A5 (en) 1983-01-14
DE2824535C3 (de) 1981-01-22
DE2824535A1 (de) 1978-12-14
PH26810A (en) 1992-11-05
IN149747B (xx) 1982-04-03
NO781970L (no) 1978-12-08
DK155740B (da) 1989-05-08
SG65383G (en) 1985-03-29
IE47079B1 (en) 1983-12-14
FR2393804A1 (fr) 1979-01-05
NO151746C (no) 1985-06-05
ATA128580A (de) 1981-02-15
BE867859A (fr) 1978-12-06
AU3683878A (en) 1979-12-06
FR2393804B1 (xx) 1980-11-07
SU860706A1 (ru) 1981-08-30
OA05964A (fr) 1981-06-30
NO152448B (no) 1985-06-24
NO152448C (no) 1985-10-02
NO151746B (no) 1985-02-18
SE436206B (sv) 1984-11-19
DE2857263B2 (de) 1981-04-23
AR224111A1 (es) 1981-10-30
GR72255B (xx) 1983-10-06
YU117078A (en) 1983-01-21
PH21116A (en) 1987-07-16
DE2857263C3 (de) 1981-12-17
NL180009C (nl) 1986-12-16
KE3355A (en) 1983-12-16
PT68146A (en) 1978-07-01
EG13869A (en) 1983-03-31
MY8500092A (en) 1985-12-31
NL930064I1 (nl) 1993-09-01
PL207396A1 (pl) 1979-06-04

Similar Documents

Publication Publication Date Title
FI66003C (fi) Analogifoerfarande foer framstaellning av en terapeutiskt anvaendbar penicillansyra-1,1-dioxid och derivat daerav
US4234579A (en) Penicillanic acid 1,1-dioxides as β-lactamase inhibitors
KR840000797B1 (ko) 6β-하이드록시알킬페니실란산 유도체의 제조방법
US4276285A (en) Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid
FI67552C (fi) Foerfarande foer framstaellning av en ny som beta-laktamas-inhibitor anvaendbar 2beta-acetoxymetyl-2alfa-metyl-(5r)-penam-3alfa-karboxylsyra-1,1-dioxid
US4420426A (en) 6-Alpha-halopenicillanic acid 1,1-dioxides
FI70024B (fi) Foerfarande foer framstaellning av penicillansyra-1,1-dioxid och dess estrar
CS236681B2 (en) Manufacturing process of 1,1-dioxide ester 2beta-substituted 2alfa-methyl 5r penam-3alfa-carboxyl acid
DD149366A5 (de) Verfahren zur herstellung von penicillansaeure-derivaten
EP0083977A1 (en) 6-Alpha-hydroxymethylpenicillanic acid sulfone as a beta-lactamase inhibitor
US4762920A (en) 6,6-Dihalopenicillanic acid 1,1-dioxides
US4714761A (en) 6,6-dihalopenicillanic acid 1,1-dioxides and process
KR820000740B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
KR810002025B1 (ko) 페니실란산 1, 1-디옥사이드의 제조방법
JPS6145993B2 (xx)
CA1129773A (en) PENICILLANIC ACID 1,1-DIOXIDES AS .beta.-LACTAMASE INHIBITORS
NZ199608A (en) Administering penicillanic acid 1,1-dioxides with beta-lactam antibiotics
NZ199601A (en) Coadministration of a cephalosporin derivative and a penicillin
JPH0534336B2 (xx)
HU180921B (hu) Eljárás beta-laktám antibiotikumot és 2,2-dimetil-penam-3- -karbonsav-l,l-dioxid-származékokat tartalmazó gyógyászati készítmények előállítására

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: PFIZER INC.